Identifying New Tumor Antigens for Breast Cancer Prevention
Author Information
Author(s): Cavallo Federica, Astolfi Annalisa, Iezzi Manuela, Cordero Francesca, Lollini Pier-Luigi, Forni Guido, Calogero Raffaele
Primary Institution: University of Torino
Hypothesis
Can a meta-analysis of transcription profiles identify new tumor-associated antigens (TAAs) for breast cancer immunological prevention?
Conclusion
This pilot study suggests that meta-analysis of expression profiles can help design pre-clinical immunopreventive vaccines.
Supporting Evidence
- Five TAAs were identified that are expressed in human breast tumors and have low expression in normal tissues.
- The study utilized transcriptional profiling to correlate gene expression with tumor mass increase.
- The identified TAAs could assist in designing vaccines for breast cancer prevention.
Takeaway
Researchers looked for new targets to help the immune system fight breast cancer by studying specific genes in mice. They found some promising candidates that could be used in vaccines.
Methodology
A meta-analysis of transcription profiles from BALB-neuT mice was performed to identify new TAAs.
Potential Biases
The partial coverage of the mouse transcriptome by the arrays used could introduce bias.
Limitations
The study may have missed other interesting TAAs due to increased experimental noise from integrating two independent experiments.
Participant Demographics
The study used BALB-neuT transgenic mice, which develop mammary tumors.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website